{"id":816213,"date":"2025-02-21T08:05:26","date_gmt":"2025-02-21T13:05:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/"},"modified":"2025-02-21T08:05:26","modified_gmt":"2025-02-21T13:05:26","slug":"madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/","title":{"rendered":"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CONSHOHOCKEN, Pa., Feb.  21, 2025  (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET.<\/p>\n<p>The presentation will be webcast live and may be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kDS4QkFiEv3D8NQhF8jKS5zRiHN2s4rZC-q1sOFTG_XcEtw8GqCHWE1crbSBUoY2uFF4G-dy-FacixcKAt5wlutMcfhrzeZumBMJp5ZCc9W2JqtFOby8IAymI8Nwu9cgNvjwWlnL02j4TCnuOyTzIB0ay8dOLnk1C-fPRorV2ZBIexoQJmgtIRhp3-QnIeC7\" rel=\"nofollow\" target=\"_blank\">here<\/a> or by visiting Madrigal\u2019s Investor Relations Events <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7ZsbLE_9qAh1urrMUE6GWnmiU7ev0PdjattZ32UBp7UBZjfLbNjnGGABdUdNDnH0hiPimbDb4NdTNn_3ff2dlax-Y-RjLL3s9BfRkntkm-FNQ-LFoLXXTm-TvFwjqooG\" rel=\"nofollow\" target=\"_blank\">page<\/a>. A replay of the webcast will be available after the event.<\/p>\n<p>\n        <strong>About Madrigal Pharmaceuticals<\/strong><br \/>\n        <br \/>Madrigal Pharmaceuticals, Inc.\u00a0(Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal\u2019s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-\u03b2 agonist designed to target key underlying causes of MASH. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mohpXr-iYegSmNPN1FquAMQC6mVtGxv-s2WmCvTJ-Q2FASG2QBTieox2-S64qNjy8RYTvLt6tP_Qx1_q5NXfNEmKvs77UgXLWjbDzQUULOQ_3Z-8NGUxJmPMcnWXsR2Bw_ay1VAVENB7G8hTZ2kHZEpQ2E4bWMJUDyQVEaR7RkVOVUIDGSJxeEWfzV22fANNICZTC6Kd8PvDzUHGOR0u0t0SsygD-V_E2p12rzRJ3ThSWXbMvjzsA-My-zViGq6aYGXefuV946qnUorenJB0HOmMegEBKqobHzCyYUFuZ-psA0Y7QrhBo_5NJJKpbGcHaz-RQrj26qHH2XmfuI7yqqSlB5lRWEcOmBMmQQBenDZDEqwj6Aem5v3wBI-LYk-xZYjt3OjjjfcKW_2IrUi5JkA16Nr-OhQGsDGjRDjsOzxJgHu7E4Bd84PX9SBG1FcrtNrJsd8st6JKFxkU3d8JMjabg7eOuPvR3XIRnq5fizOscPwUhQfPjRdreMQC4OgvzJNWm-jVTnK_4gT3xI4MLunNlDqcvW8Ua7jm-QacVC0KvCh5i0lMIL88hKhCUQfrCmCU-KW28wiQTHVVjLMe13kqgwIyq2WjqnrzJ5XBLbTPNdP96U0xQ1oKosv8aoB0qwszk458I5zC1Erq5Rto8kzZoDN_DNqUQJcFHan_PFtYJJ39tKcX6d4pcRr6_Ui_5tZZe62SAoxQCvibynyuwK1SGRvAWSJB07fiJbgVL9Q-NSn0Wo4ULw-2zGNF6KaIQdqA04rq1O_zx41dIT4XDQ-wtxSpbDK80I7s5Xn8TSc=\" rel=\"nofollow\" target=\"_blank\">www.madrigalpharma.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Tina Ventura, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-_i32GPAIqXKFFZCEF1QQfwkSmNbLcYgVaWcX3dRe7R5fR2yGdJkgCpOC6t6hZNhCJfRXs8ObBTnRTVGKP_ziBarVkQUihsFeNS582O6xc4=\" rel=\"nofollow\" target=\"_blank\">IR@madrigalpharma.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Christopher Frates,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eZtvLuiqAa-Vj87qvKySeHlZztQLWKFT1dUxjvQs0ONCrG0Jkd4TWK_GzLaPQ6V5mx2Mjmzzv9efb_k-ufEqXUoEh6snIm9AL6vpH2B75to=\" rel=\"nofollow\" target=\"_blank\">media@madrigalpharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDg0NWUyOWQtYmI0Mi00YjIzLWEyNGMtY2MxZjAxNjUzMGRkLTEwMTc3ODY=\/tiny\/Madrigal-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET. The presentation will be webcast live and may be accessed here or by visiting Madrigal\u2019s Investor Relations Events page. A replay of the webcast will be available after the event. About Madrigal Pharmaceuticals Madrigal Pharmaceuticals, Inc.\u00a0(Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal\u2019s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-\u03b2 agonist designed to target key underlying causes of MASH. For more information, visit\u00a0www.madrigalpharma.com. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816213","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET. The presentation will be webcast live and may be accessed here or by visiting Madrigal\u2019s Investor Relations Events page. A replay of the webcast will be available after the event. About Madrigal Pharmaceuticals Madrigal Pharmaceuticals, Inc.\u00a0(Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal\u2019s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-\u03b2 agonist designed to target key underlying causes of MASH. For more information, visit\u00a0www.madrigalpharma.com. &hellip; Continue reading &quot;Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-21T13:05:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference\",\"datePublished\":\"2025-02-21T13:05:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/\"},\"wordCount\":149,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/\",\"name\":\"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=\",\"datePublished\":\"2025-02-21T13:05:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference - Market Newsdesk","og_description":"CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET. The presentation will be webcast live and may be accessed here or by visiting Madrigal\u2019s Investor Relations Events page. A replay of the webcast will be available after the event. About Madrigal Pharmaceuticals Madrigal Pharmaceuticals, Inc.\u00a0(Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal\u2019s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-\u03b2 agonist designed to target key underlying causes of MASH. For more information, visit\u00a0www.madrigalpharma.com. &hellip; Continue reading \"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-21T13:05:26+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference","datePublished":"2025-02-21T13:05:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/"},"wordCount":149,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/","name":"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=","datePublished":"2025-02-21T13:05:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjIwMSM2NzYxNjg1IzIwMDYyMTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-to-participate-in-the-45th-annual-td-cowen-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816213"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816213\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}